Pyxis Oncology (PYXS) Other Non-Current Assets (2020 - 2022)

Pyxis Oncology (PYXS) has 3 years of Other Non-Current Assets data on file, last reported at $1.5 million in Q3 2022.

• On a quarterly basis, Other Non-Current Assets rose 1250.46% year-over-year to $1.5 million in Q3 2022; TTM through Sep 2022 was $1.5 million, a 1250.46% increase from a year earlier, with the FY2021 full-year figure at $109000.0, changed 0.0% from the prior year.
• Other Non-Current Assets for Q3 2022 stood at $1.5 million, roughly flat from $1.5 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for PYXS reached as high as $1.5 million in Q2 2022 and fell as low as $108000.0 in Q2 2021.
• Historically, Other Non-Current Assets has averaged $492125.0 across 3 years, with a median of $109000.0 in 2020.
• Across the five-year window, Other Non-Current Assets changed 0.0% in 2021 and jumped 1262.96% in 2022, its largest moves.
• Year by year, Other Non-Current Assets stood at $109000.0 in 2020, then changed by 0.0% to $109000.0 in 2021, then surged by 1250.46% to $1.5 million in 2022.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.5 million in Q3 2022, $1.5 million in Q2 2022, and $449000.0 in Q1 2022.